Phillip Dougherty
Biography
Research: Phillip will be investigating the use of induced pluripotent stem cells (iPSC) in generating induced regulatory T cells (Tregs) as a cellular therapy for Graft Versus Host Disease. This process involves genetically modifying iPSC to increase their stability and propensity to differentiate into functioning Tregs and verifying the generated Tregs using genomic, proteomic, metabolomic and functional
assays.
